Clinical trial NCT06160102: Safe Drug Use in People With Intellectual and/or Developmental Disabilities - it Applies to Life
Official title: Safe Drug Use in People With Intellectual and/or Developmental Disabilities - it Applies to Life
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Disabilities, Intellectual
Disability, Developmental
Keywords: Intellectual Disabilities
Developmental Disabilities
Intersectoral Collaboration
Medication Therapy Management
Medication Reconciliation
Medication Review
Lead sponsor: Vestvagoy Municipality
Sponsor class: OTHER
Collaborators: name: University of Oslo
name: University of Tromso
First posted: 2023-12-07
Enrollment: 110
Sex: ALL
Minimum age (years): 1
Maximum age (years): 99
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Participatory action research
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: The innovation idea is to develop valuable new knowledge about safe drug use in people with intellectual and/or developmental disabilities (IDDs). The main goal is to design a framework (routines and processes) that ensures safe drug use and provides qualitatively better services for people with IDDs. Secondary goals are that employees will experience better security when working with medicines, and interact better with people with IDD and relatives by implementing digital support functions. The innovation idea is specifically to develop/improve the following: 1) Medication management: Coordinating routines, procedures and work processes regarding all aspects of drug use, medication handling, and communication between care units for people with IDDs. 2) Medication therapy: Chart review of prescribed medication and gather knowledge about challenges related to drug use in this group. Based on this, we will develop new methods for drug reconciliation and medication reviews to optimize drug use. 3) New framework for safe drug use in the community-based services for people with IDDs.

Detailed description: Changing, developing, and testing new routines, procedures, and communication methods for safe drug use is challenging. The complexity of systems that are involved in medication management makes it particularly challenging to create well-designed digital solutions that ensure good working procedures. The complex issues faced by people with IDDs, as well as developments within personalized medicine, means that it is crucial to build new knowledge, work in teams, and arrange for medication reconciliation and medication reviews to be carried out regularly. Furthermore, drug information must be provided, and adapted to the specific individual with an intellectual disability. In addition, the focus on personalized medicine means that the municipality must develop new guidelines for the use of pharmacogenetic tests so that the doctor can tailor drug selection and dosage to the individual patient.

Eligibility criteria: Inclusion Criteria:

* Users of the municipality's Service for people with disabilities

Exclusion Criteria:

-

Primary outcomes:
measure: To understand what is safe drug therapy and drug handling in people with intellectual and/or developmental disabilities
timeFrame: 12 months
measure: Formulation of multidisciplinary frameworks for optimizing drug handling and drug therapy.
timeFrame: 18 months
measure: Explore usefulness of multidisciplinary frameworks
timeFrame: 18 months
Secondary outcomes:
Other outcomes:
Locations:
city: Leknes
country: Norway
facility: Vestvågøy Municipality
Study officials:
affiliation: Vestvågøy Municipality
name: Heidi Wiik, MBA
role: STUDY_DIRECTOR
References: